During the past decade, Carolinas Center for Liver Disease conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 7 clinical trials were completed, i.e. on average, 700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolinas Center for Liver Disease" #1 collaborator was "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Carolinas Center for Liver Disease" are "Hepatitis C" (7 trials), "Chronic Hepatitis C" (2 trials), "Hepatitis C Virus" (2 trials), "Hepatitis C, Chronic" (2 trials) and "Hepatitis C Infection" (1 trials). Many other conditions were trialed in "Carolinas Center for Liver Disease" in a lesser frequency.

Most popular intervention types in "Carolinas Center for Liver Disease" are "Drug" (14 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Daclatasvir" (4 trials), "Ribavirin" (4 trials), "RBV" (3 trials) and "ribavirin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Carolinas Center for Liver Disease" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Carolinas Center for Liver Disease". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Carolinas Center for Liver Disease, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Carolinas Center for Liver Disease, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".